PCN18 LETROZOLE (FEMARA) IS A COST-EFFECTIVE TREATMENT IN THE EXTENDED ADJUVANT SETTING IN WOMEN WITH EARLY BREAST CANCER- AN APPLICATION TO CANADA
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67256-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67256-7/fulltext
Title :
PCN18 LETROZOLE (FEMARA) IS A COST-EFFECTIVE TREATMENT IN THE EXTENDED ADJUVANT SETTING IN WOMEN WITH EARLY BREAST CANCER- AN APPLICATION TO CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67256-7&doi=10.1016/S1098-3015(10)67256-7
First page :
Section Title :
Open access? :
No
Section Order :
483